Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Keywords
(8)
Enzyme
Missense Mutation
Tumor Suppressor
Ubiquitin Ligase
Molecular Weight
Tumor Suppressor Gene
von hippel lindau disease
von hippel lindau
Subscribe
Academic
Publications
Identification of the von Hippel-Lindau Tumor-Suppressor Protein as Part of an Active E3 Ubiquitin Ligase Complex
Identification of the von Hippel-Lindau Tumor-Suppressor Protein as Part of an Active E3 Ubiquitin Ligase Complex,10.1073/pnas.96.22.12436,Proceedings
Edit
Identification of the von Hippel-Lindau Tumor-Suppressor Protein as Part of an Active E3 Ubiquitin Ligase Complex
(
Citations: 173
)
BibTex
|
RIS
|
RefWorks
Download
Kazuhiro Iwai
,
Koji Yamanaka
,
Takumi Kamura
,
Nagahiro Minato
,
Ronald C. Conaway
,
Joan W. Conaway
,
Richard D. Klausner
,
Arnim Pause
Mutations of von Hippel-Lindau disease (VHL) tumor-suppressor gene product (pVHL) are found in patients with dominant inherited VHL syndrome and in the vast majority of sporadic clear cell renal carcinomas. The function of the pVHL protein has not been clarified. pVHL has been shown to form a complex with elongin B and elongin C (VBC) and with cullin (CUL)-2. In light of the structural analogy of VBC-CUL-2 to SKP1-CUL-1-F-box ubiquitin ligases, the
ubiquitin ligase
activity of VBC-CUL-2 was examined in this study. We show that VBC-CUL-2 exhibits
ubiquitin ligase
activity, and we identified UbcH5a, b, and c, but not CDC34, as the ubiquitin-conjugating enzymes of the VBC-CUL-2 ubiquitin ligase. The protein Rbx1/ROC1 enhances ligase activity of VBC-CUL-2 as it does in the SKP1-CUL-1-F-box protein ligase complex. We also found that pVHL associates with two proteins, p100 and p220, which migrate at a similar
molecular weight
as two major bands in the ubiquitination assay. Furthermore, naturally occurring pVHL missense mutations, including mutants capable of forming a complex with elongin B-elongin C-CUL-2, fail to associate with p100 and p220 and cannot exhibit the E3 ligase activity. These results suggest that pVHL might be the substrate recognition subunit of the VBC-CUL-2 E3 ligase. This is also, to our knowledge, the first example of a human tumor-suppressor protein being directly involved in the ubiquitin conjugation system which leads to the targeted degradation of substrate proteins.
Journal:
Proceedings of The National Academy of Sciences - PNAS
, vol. 961, no. 22, pp. 12436-12441, 1999
DOI:
10.1073/pnas.96.22.12436
Cumulative
Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
(
adsabs.harvard.edu
)
(
www.pnas.org
)
Citation Context
(42)
...In addition to VHL, the E3 ligase complex is formed by the RING-finger protein RBX1, which is thought to recognise a cognate E2, as well as several adaptor proteins, such as elongin B, elongin C and cullin 2 [
22
, 23] (Fig. 1). The asparagine 803 residue of HIF-1α is also hydroxylated under normoxic conditions by a specific asparagine hydroxylase named factor-inhibiting HIF-1 (FIH-1), which impairs the interaction of the transcriptional ...
C. F. Bento
,
et al.
Regulation of hypoxia-inducible factor 1 and the loss of the cellular ...
... 3) led to the demonstration that the VHL complex is an E3 (Ref
...
Stanley Lipkowitz
,
et al.
RINGs of good and evil: RING finger ubiquitin ligases at the crossroad...
...,
...
Raffi Bekeredjian
,
et al.
Conditional HIF-1alpha Expression Produces a Reversible Cardiomyopathy
...This complex has E3 ubiquitin ligase activity, the VHL protein (pVHL) being the substrate recognition component [
2
, 3]. According to the clinical manifestations, the disease has been classifi ed into VHL type 1, type 2 and type 3. Type 2 is further classifi ed into three categories: type 2A, type 2B and type 2C. Most type 1 families have deletions or premature termination mutations whereas type 2 families are mostly affected by missense ...
María J. Calzada
.
Von Hippel-Lindau syndrome: molecular mechanisms of the disease
... Purification of recombinant proteins was performed as described previousl
...
Fuminori Tokunaga
,
et al.
Involvement of linear polyubiquitylation of NEMO in NF-κB activation
Sort by:
Citations
(173)
pVHL Mediates K63Linked Ubiquitination of nCLU
Jing Xue
,
Dan-dan Lv
,
Shi Jiao
,
Wenting Zhao
,
Xuebing Li
,
Heng Sun
,
Bing Yan
,
Li Fan
,
Rong-gui Hu
,
Jing Fang
Journal:
PLOS One
, vol. 7, no. 4, 2012
SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex
(
Citations: 10
)
Fuminori Tokunaga
,
Tomoko Nakagawa
,
Masaki Nakahara
,
Yasushi Saeki
,
Masami Taniguchi
,
Shin-Ichi Sakata
,
Keiji Tanaka
,
Hiroyasu Nakano
,
Kazuhiro Iwai
Journal:
Nature
, vol. 471, no. 7340, pp. 633-636, 2011
Regulation of hypoxia-inducible factor 1 and the loss of the cellular response to hypoxia in diabetes
(
Citations: 1
)
C. F. Bento
,
P. Pereira
Journal:
Diabetologia
, vol. 54, no. 8, pp. 1946-1956, 2011
Formation of single-crystalline rutile TiO 2 splitting microspheres for dye-sensitized solar cells
Jiang Sheng
,
Linhua Hu
,
Wenxin Li
,
Li’e Mo
,
Huajun Tian
,
Songyuan Dai
Journal:
Solar Energy - SOLAR ENERG
, vol. 85, no. 11, pp. 2697-2703, 2011
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis
Stanley Lipkowitz
,
Allan M. Weissman
Journal:
Nature Reviews Cancer - NAT REV CANCER
, vol. 11, no. 9, pp. 629-643, 2011